NRC Health — Earnings
Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR
Next earnings (estimated): Wed, April 1, 2026 — 30 days overdue (likely already filed but EDGAR cache cold). Anchored to latest quarter-end + 91 days. Analyst-confirmed dates land in a follow-up wave.
YoY = vs same quarter prior year (seasonality-adjusted)
Recent earnings · last 8 quarters
| Quarter end | Revenue | YoY | Net Income | YoY | Op. Margin |
|---|---|---|---|---|---|
| 2025-12-31 | $35M | ↓-4.6% | $2M | ↓-72.6% | 13.3% |
| 2025-09-30 | $35M | ↓-3.4% | $4M | ↓-27.5% | 22.4% |
| 2025-06-30 | $34M | ↓-2.8% | $-106K | ↓-101.7% | 4.7% |
| 2025-03-31 | $34M | ↓-5.0% | $6M | ↓-9.0% | 25.6% |
| 2024-12-31 | $37M | ↓-2.9% | $7M | ↓-25.9% | 26.0% |
| 2024-09-30 | $36M | ↓-5.6% | $6M | ↓-27.8% | 22.3% |
| 2024-06-30 | $35M | ↓-3.2% | $6M | ↓-15.1% | 25.3% |
| 2024-03-31 | $35M | ↓-3.2% | $6M | ↓-8.7% | 24.8% |
Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.
Last earnings · FY2025 (Q4)
Revenue
$35M
↓-4.6% -$2M YoY
Net Income
$2M
↓-72.6% -$5M YoY
Earnings surprise · last 8 quarters
YoY % change · proxy for analyst surprise until estimates landEPS history · last 10 fiscal years
diluted, GAAP, annualNote: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.
Go deeper
NRC Sankey — flow of dollars
See how revenue waterfalls through every line item to net income for the latest reported quarter, with prior-period comparison.
Open SankeyNRC Key Metrics — EPS, ROE, ROIC
10 CFA-grade fundamental ratios — EPS, BVPS, ROE, ROA, ROIC, Debt/Equity, Current Ratio. Compare across years.
Open Key Metrics